Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 37Unknown 9Terminated 6Withdrawn 3Recruiting 3Suspended 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia 1Breast Neoplasms 1

Interventions

Trastuzumab 2Taxes 2Paclitaxel 2Fluorouracil 2Cyclophosphamide 2trastuzumab biosimilar HLX02 1tivozanib 1taletrectinib 1palbociclib 1eribulin 1atezolizumab 1Tomography, Optical Coherence 1Testosterone Propionate 1Testosterone 1Tamoxifen 1Tablets 1Specimen Handling 1Receptors, Chimeric Antigen 1Radiotherapy 1PF-05280014 1Ontruzant 1Ogivri 1Neoadjuvant Therapy 1Methotrexate 1Mastectomy, Segmental 1Lisaftoclax 1Interpersonal Psychotherapy 1Interleukin-2 1Injections 1G(M1) Ganglioside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Breast Neoplasms × Methotrexate × Clear all
NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Suspended
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡